Elucidation of the genetic mechanisms contributing to moenomycin resistance in actinobacteria
Abstract
Aim. Moenomycins are phosphoglycolipid antibiotics produced almost exclusively by representatives of genus Streptomyces. These antibiotics directly inhibit peptidoglycan glycosyltransferases and are extremely active against cocci. Here we studied how antibiotic-producing actinobacteria protect themselves from toxic action of moenomycins. Methods. Microbiological and molecular genetic approaches were combined to reveal intrinsic levels and distribution of moenomycin resistance across actinobacteria genera, and to pinpoint genes contributing to moenomycin resistance in model strain Streptomyces coelicolor M145. Results. Out of 51 actinobacterial species (90 % of which Streptomyces) being tested, only Streptomyces albus J1074 turned out to be highly susceptible to moenomycin A, although resistant variants can be facilely raised. Several classes of mutations increased level of susceptibility of S. coelicolor to moenomycin, although in no case the latter was equal to what we observed in J1074 strain. Conclusions. Moenomycin resistance is widespread across actinobacteria, and it most likely is caused by a combination factors, such as richly decorated cell wall and organization of divisome apparatus. It is possible that moenomycin resistance mechanisms operating in actinobacteria and pathogenic cocci are different.
Keywords: moenomycin, antibiotic resistance, peptidoglycan.
References
Ostash B., Walker S. Bacterial transglycosylase inhibitors. Curr. Opin. Chem. Biol. 2005. Vol. 9. P. 459–466. doi: 10.1016/j.cbpa.2005.08.014.
Taylor J.G., Chen X., Kahne D.. The total synthesis of moenomycin A. J. Am. Chem. Soc. 2006. 128. P. 15084–15085. doi: 10.1021/ja065907x.
Ostash B., Walker S. Moenomycin family antibiotics: chemical synthesis, biosynthesis, and biological activity. Nat. Prod. Rep. 2010. Vol. 27. P. 1594–1617. doi: 10.1039/c001461n.
Ostash B., Doud E., Fedorenko V. The molecular biology of moenomycins: towards novel antibiotics based on inhibition of bacterial peptidoglycan glycosyltransferases. Biol. Chem. 2010. Vol. 391. P. 499–504. doi: 10.1515/BC.2010.053.
Wright G.D. Antibiotic resistance in the environment: a link to the clinic? Curr. Opin. Microbiol. 2010. Vol. 13. P. 589–594. doi: 10.1016/j.mib.2010.08.005.
Klare I., Mascher J. Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int. J. Food Microbiol. 2003. 88. P. 269–290. doi: 10.1016/S0168-1605(03)00190-9.
Kieser T., Bibb M.J., Buttner M.J., Hopwood D.A. Practical Streptomyces Genetics. The John Innes Foundation, Norwich, (UK), 2000. 630 p.
Bishop A., Dyson P. Systematic insertional mutagenesis of a streptomycete genome: a link between osmoadaptation and antibiotic production. Genome Res. 2004. V. 14. P. 893–900. doi: 10.1101/gr.1710304.
Shashkov A.S., Ostash B.O., Fedorenko V. Cell wall glycopolymers of Streptomyces albus, Streptomyces albidoflavus and Streptomyces pathocidini. Antonie Van Leeuw. 2016. Vol. 109. P. 923–936. doi: 10.1007/s10482-016-0691-8.
Barrett D., Yanqiu Y., Walker S. Analysis of glycan polymers produced by peptidoglycan glycosyltransferases. J. Biol. Chem. 2007. Vol. 282. P. 31964–31971. doi: 10.1074/jbc.M705440200.
Rebets Y., Lupoli T., Schiener K., Kahne D., Walker S. Moenomycin resistance mutations in Staphylococcus aureus reduce peptidoglycan chain length and cause aberrant cell division. ACS Chem Biol. 2014. Vol. 9. P. 459–467. doi: 10.1021/cb4006744.
Meeske A.J., Mekalanos J., Walker S., Kahne D., Rudner D. SEDS proteins are a widespread family of bacterial cell wall polymerases. Nature. 2016. Vol. 537. P. 634–638. doi: 10.1038/nature19331.
Ladwig N., Wohlleben W., Muth G. Control of morphological differentiation of Streptomyces coelicolor A3(2) by phosphorylation of MreC and PBP2. PLoS One. 2015. Vol. 10. P. e0125425. doi: 10.1371/journal.pone.0125425.
Ruiz N. Lipid flippases for bacterial peptidoglycan biosynthesis. Lipid Insights. 2016. Vol. 8. P. 21–31. doi: 10.4137/LPI.S31783.
